Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 4
2019 10
2020 15
2021 2
2022 1
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR Jr, Minsky BD, Ludmir EB. Pasalic D, et al. Among authors: lin ta. Eur J Cancer. 2020 Sep;136:176-185. doi: 10.1016/j.ejca.2020.06.015. Epub 2020 Jul 20. Eur J Cancer. 2020. PMID: 32702645 Free PMC article. Review.
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials.
Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee JJ, Kupferman M, Raghav KP, Overman MJ, Thomas CR Jr, Ludmir EB. Florez MA, et al. Among authors: lin ta. JAMA Netw Open. 2023 May 1;6(5):e2313819. doi: 10.1001/jamanetworkopen.2023.13819. JAMA Netw Open. 2023. PMID: 37195664 Free PMC article. Clinical Trial.
Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials.
Pasalic D, Fuller CD, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Grossberg AJ, Jagsi R, Das P, Koong AC, Rödel C, Fokas E, Thomas CR Jr, Minsky BD, Ludmir EB. Pasalic D, et al. Among authors: lin ta. Mayo Clin Proc. 2021 Feb;96(2):420-426. doi: 10.1016/j.mayocp.2020.08.015. Mayo Clin Proc. 2021. PMID: 33549260 Review.
The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology.
Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Verma V, VanderWalde NA, Grossberg AJ, Guadagnolo BA, Koong AC, Jagsi R, Thomas CR, Fuller CD. Ludmir EB, et al. Among authors: lin ta. J Natl Cancer Inst. 2019 Dec 1;111(12):1358-1360. doi: 10.1093/jnci/djz117. J Natl Cancer Inst. 2019. PMID: 31165160 Free PMC article. Review.
Sex-Based Disparities Among Cancer Clinical Trial Participants.
Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E. Ludmir EB, et al. Among authors: lin ta. J Natl Cancer Inst. 2020 Feb 1;112(2):211-213. doi: 10.1093/jnci/djz154. J Natl Cancer Inst. 2020. PMID: 31350545 Free PMC article.
39 results